Biotech

All Articles

Analysts dig into Avidity's DMD succeed, exposing subtleties in information

.Avidity Biosciences pleased entrepreneurs with period 1/2 data in Duchenne muscle dystrophy (DMD) F...

Actinogen's cortisol blocker fails stage 2 anxiety research study

.Actinogen Medical's cortisol blocker has actually skipped the main endpoint of a phase 2 study in c...

Bivictrix determines going personal only way to take ADC right into medical clinic

.Antibody-drug conjugates (ADCs) have actually been at the center of a lot of a billion-dollar biobu...

TPG bests up funds to $580M for financial investments throughout lifestyle scientific researches

.Resource supervisor TPG, which has actually assisted biotechs like Sionna Therapies as well as Sant...

Merck stops stage 3 TIGIT test in bronchi cancer cells for futility

.Merck &amp Co.'s TIGIT plan has actually gone through one more misfortune. Months after shuttering ...

After a difficult year, Exscientia folds into Recursion

.After a year defined through pipeline hairstyles, the shift of its own CEO as well as unemployments...

Cullinan, after $25M deal, return bispecific to Harbour

.Cullinan Therapy was actually blown away good enough with Harbour BioMed's bispecific invulnerable ...

A more detailed look at Fierce Biotech's Fierce 15

.In this week's episode of "The Best Line," our experts're diving into Fierce Biotech's yearly Fierc...

Lilly encounters phase 2 failure of tau-targeting med

.The confetti is actually still soaring from Eli Lilly's event celebrating the approval of Alzheimer...

Biogen CMO Maha Radhakrishnan participates in Sofinnova-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our roundup of significant leadership hirings, shootings...